High expression of PRMT5 in tumors is associated with poor prognosis in patients with cervical cancer, whereas PRMT5 deficiency leads to an increased number of tumor-infiltrating T cells and enhances their function [348]. The gene discussed is PRMT5; the disease is cervical cancer.